Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
276
Ball Corp
BALL
$17.5B
| $100M | 0.06% |
1,553,717
+322,164
| +26% | +$21.8M |
|
277
Deere & Co
DE
$165B
| $100M | 0.06% |
578,995
+86,067
| +17% | +$14.8M |
|
278
LyondellBasell Industries
LYB
$19.5B
| $99.9M | 0.06% |
1,057,750
-115,641
| -10% | -$10.6M |
|
279
Boston Scientific
BSX
$68.4B
| $99.8M | 0.06% |
2,207,099
+275,882
| +14% | +$11.5M |
|
280
Emerson Electric
EMR
$81.6B
| $97.9M | 0.05% |
1,284,170
+121,515
| +10% | +$8.76M |
|
281
CALL
Micron Technology
MU
$835B
| $95.9M | 0.05% |
1,782,500
+419,400
| +31% | +$20M |
|
282
Northrop Grumman
NOC
$76B
| $95.6M | 0.05% |
277,961
+49,270
| +22% | +$17.3M |
|
283
Crown Castle
CCI
$34.6B
| $95.6M | 0.05% |
672,590
+83,308
| +14% | +$11.4M |
|
284
Digital Realty Trust
DLR
$69.6B
| $95.4M | 0.05% |
796,848
+420,132
| +112% | +$51.7M |
|
285
Kinder Morgan
KMI
$70.9B
| $93.3M | 0.05% |
4,406,735
+827,908
| +23% | +$16.8M |
|
286
CALL
CVS Health
CVS
$135B
| $92.6M | 0.05% |
1,245,896
+469,477
| +60% | +$33M |
|
|
LOGM
287
DELISTED
LogMein, Inc.
LOGM
| $92M | 0.05% |
1,072,417
+997,651
| +1,334% | +$74M |
|
288
Zimmer Biomet
ZBH
$18.8B
| $91.8M | 0.05% |
631,583
-71,102
| -10% | -$9.81M |
|
289
Sysco
SYY
$40.8B
| $91.5M | 0.05% |
1,069,612
+506,524
| +90% | +$41M |
|
290
CALL
iShares Silver Trust
SLV
$27.7B
| $91.3M | 0.05% |
5,475,500
-977,400
| -15% | -$15.8M |
|
291
Southern Company
SO
$108B
| $91.2M | 0.05% |
1,431,319
+229,553
| +19% | +$14.2M |
|
292
Regeneron Pharmaceuticals
REGN
$72.9B
| $91M | 0.05% |
242,340
-23,854
| -9% | -$8.03M |
|
293
General Mills
GIS
$20.2B
| $90.8M | 0.05% |
1,694,865
+724,161
| +75% | +$38.2M |
|
294
PUT
GE Aerospace
GE
$364B
| $90.8M | 0.05% |
1,631,778
-27,547
| -2% | -$1.42M |
|
295
Invesco Senior Loan ETF
BKLN
$6.96B
| $90.7M | 0.05% |
3,975,368
+3,192,878
| +408% | +$72M |
|
296
Eaton
ETN
$141B
| $90.6M | 0.05% |
956,074
+331,055
| +53% | +$29.4M |
|
297
Aflac
AFL
$65.5B
| $90.1M | 0.05% |
1,702,388
+128,246
| +8% | +$6.81M |
|
298
Marathon Petroleum
MPC
$90.1B
| $89.4M | 0.05% |
1,483,917
+390,727
| +36% | +$24.4M |
|
299
Prudential Financial
PRU
$42.6B
| $88.8M | 0.05% |
947,215
+53,813
| +6% | +$4.94M |
|
300
Global Payments
GPN
$24.1B
| $88.6M | 0.05% |
485,192
+32,032
| +7% | +$5.5M |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.